Page 2 - Pypd News Today

PolyPid Ltd. (NASDAQ:PYPD – Free Report) was the target of a large drop in short interest in June. As of June 15th, there was short interest totalling 88,000 shares, a drop of 29.1% from the May 31st total of 124,100 shares. Based on an average daily volume of 112,600 shares, the days-to-cover ratio is currently […]

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) shares traded up 4.8% during trading on Wednesday . The stock traded as high as $0.39 and last traded at $0.37. 94,833 shares were traded during trading, a decline of 67% from the average session volume of 288,958 shares. The stock had previously closed at $0.35. PolyPid Price Performance […]

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) was down 1.2% during trading on Tuesday . The company traded as low as $0.40 and last traded at $0.41. Approximately 17,516 shares changed hands during trading, a decline of 95% from the average daily volume of 325,541 shares. The stock had previously closed at $0.41. PolyPid Stock Down […]

Raymond James Financial Services Advisors Inc. trimmed its position in shares of PolyPid Ltd. (NASDAQ:PYPD – Get Rating) by 36.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,814 shares of the company’s stock after selling 19,447 shares during the […]

PolyPid (NASDAQ:PYPD – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm currently has a $5.25 target price on the stock. Zacks Investment Research‘s price objective suggests a potential upside of 4.79% from […]

Wall Street analysts expect that PolyPid Ltd. (NASDAQ:PYPD – Get Rating) will announce earnings of ($0.68) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for PolyPid’s earnings. PolyPid reported earnings of ($0.47) per share during the same quarter last year, which indicates a negative year over […]

DGAP-News: Appyea SleepX applies to the Helsinki Committee for approval on its clinical trial with the SleepX PRO smartphone application 23.03.2022 / 12:53 The issuer is solely responsible for the content of this announcement. SleepX, a subsidiary of AppYea (OTC: APYPD) focusing on the developme...

PolyPid Ltd. (NASDAQ:PYPD – Get Rating) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 119,900 shares, an increase of 17.1% from the February 13th total of 102,400 shares. Currently, 0.8% of the shares of the stock are sold short. Based on an […]

Brokerages expect PolyPid Ltd. (NASDAQ:PYPD – Get Rating) to announce ($0.68) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for PolyPid’s earnings. PolyPid reported earnings per share of ($0.47) in the same quarter last year, which suggests a negative year over year growth rate […]